References
Akhtar A, Xiaoyan Wang S, Ghali L,
Bell C, Wen X (2017). Recent advances in arsenic trioxide encapsulated
nanoparticles as drug delivery agents to solid cancers. Journal of
biomedical research 31 (3): 177-188.
Akıl E, Akıl MA, Varol S, Özdemir HH,
Yücel Y, Arslan D, et al. (2014). Echocardiographic epicardial
fat thickness and neutrophil to lymphocyte ratio are novel inflammatory
predictors of cerebral ischemic stroke. Journal of stroke and
cerebrovascular diseases : the official journal of National Stroke
Association 23 (9): 2328-2334.
Au WY, Kumana CR, Kou M, Mak R, Chan
GC, Lam CW, et al. (2003). Oral arsenic trioxide in the treatment
of relapsed acute promyelocytic leukemia. Blood102 (1): 407-408.
Babu CS, Ramanathan M (2011).
Post-ischemic administration of nimodipine following focal cerebral
ischemic-reperfusion injury in rats alleviated excitotoxicity,
neurobehavioural alterations and partially the bioenergetics.International journal of developmental neuroscience : the official
journal of the International Society for Developmental Neuroscience29 (1): 93-105.
Bellosta S, Corsini A (2018). Statin
drug interactions and related adverse reactions: an update.17 (1): 25-37.
Chen Y, Huang W, Yang M, Xin G, Cui W,
Xie Z, et al. (2017). Cardiotonic Steroids Stimulate Macrophage
Inflammatory Responses Through a Pathway Involving CD36, TLR4, and
Na/K-ATPase. Arteriosclerosis, thrombosis, and vascular biology37 (8): 1462-1469.
Christ A, Günther P, Lauterbach MAR,
Duewell P, Biswas D, Pelka K, et al. (2018). Western Diet
Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell172 (1-2): 162-175.e114.
Duewell P, Kono H, Rayner KJ, Sirois
CM, Vladimer G, Bauernfeind FG, et al. (2010). NLRP3
inflammasomes are required for atherogenesis and activated by
cholesterol crystals. Nature 464 (7293):1357-1361.
Fang S, Wan X, Zou X, Sun S, Hao X,
Liang C, et al. (2021). Arsenic trioxide induces macrophage
autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear
translocation and AKT/mTOR pathway. Cell death & disease12 (1): 88.
Febbraio M, Guy E, Silverstein RL
(2004). Stem cell transplantation reveals that absence of macrophage
CD36 is protective against atherosclerosis. Arteriosclerosis,
thrombosis, and vascular biology 24 (12): 2333-2338.
Febbraio M, Podrez EA, Smith JD,
Hajjar DP, Hazen SL, Hoff HF, et al. (2000). Targeted disruption
of the class B scavenger receptor CD36 protects against atherosclerotic
lesion development in mice. The Journal of clinical investigation105 (8): 1049-1056.
Güleç Başer B, İslimye Taşkın M,
Adalı E, Öztürk E, Hısmıoğulları AA, Yay A (2018). Does progesterone
have protective effects on ovarian ischemia-reperfusion injury?Journal of the Turkish German Gynecological Association19 (2): 87-93.
Grines CL (2015). Acute coronary
syndromes: Acute MI in women–the fountain of youth has run dry.Nature reviews. Cardiology 12 (6): 322-323.
Hansson GK, Hermansson A (2011). The
immune system in atherosclerosis. Nature immunology12 (3): 204-212.
Hansson GK, Libby P, Tabas I (2015).
Inflammation and plaque vulnerability. Journal of internal
medicine 278 (5): 483-493.
Hazen SL, Smith JD (2012). An
antiatherosclerotic signaling cascade involving intestinal microbiota,
microRNA-10b, and ABCA1/ABCG1-mediated reverse cholesterol transport.Circulation research 111 (8): 948-950.
Herrington W, Lacey B, Sherliker P,
Armitage J, Lewington S (2016). Epidemiology of Atherosclerosis and the
Potential to Reduce the Global Burden of Atherothrombotic Disease.Circulation research 118 (4): 535-546.
Hoseini Z, Sepahvand F, Rashidi B,
Sahebkar A, Masoudifar A, Mirzaei H (2018). NLRP3 inflammasome: Its
regulation and involvement in atherosclerosis. 233 (3):2116-2132.
Huang L, Chambliss KL, Gao X, Yuhanna
IS, Behling-Kelly E, Bergaya S, et al. (2019). SR-B1 drives
endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis.Nature 569 (7757): 565-569.
Kataoka Y, Puri R, Nicholls SJ
(2015). Inflammation, plaque progression and vulnerability: evidence
from intravascular ultrasound imaging. Cardiovascular diagnosis
and therapy 5 (4): 280-289.
Kauser K, Sonnenberg D, Diel P,
Rubanyi GM (1998). Effect of 17beta-oestradiol on cytokine-induced
nitric oxide production in rat isolated aorta. British journal of
pharmacology 123 (6): 1089-1096.
Kavurma MM, Rayner KJ, Karunakaran D
(2017). The walking dead: macrophage inflammation and death in
atherosclerosis. Current opinion in lipidology28 (2): 91-98.
Koelwyn GJ, Corr EM, Erbay E (2018).
Regulation of macrophage immunometabolism in atherosclerosis.19 (6): 526-537.
Landray MJ, Haynes R, Hopewell JC,
Parish S, Aung T, Tomson J, et al. (2014). Effects of
extended-release niacin with laropiprant in high-risk patients.The New England journal of medicine 371 (3):203-212.
Latz E, Duewell P (2018). NLRP3
inflammasome activation in inflammaging. Seminars in immunology40: 61-73.
Li H, Jiao Y, Xie M (2017).
Paeoniflorin Ameliorates Atherosclerosis by Suppressing TLR4-Mediated
NF-κB Activation. Inflammation 40 (6):2042-2051.
Monaco C, Paleolog E (2004). Nuclear
factor kappaB: a potential therapeutic target in atherosclerosis and
thrombosis. Cardiovascular research 61 (4):671-682.
Munshi NC (2001). Arsenic trioxide:
an emerging therapy for multiple myeloma. The oncologist6 Suppl 2: 17-21.
Navab M, Reddy ST, Van Lenten BJ,
Fogelman AM (2011). HDL and cardiovascular disease: atherogenic and
atheroprotective mechanisms. Nature reviews. Cardiology8 (4): 222-232.
Nicholson AC, Han J, Febbraio M,
Silversterin RL, Hajjar DP (2001). Role of CD36, the macrophage class B
scavenger receptor, in atherosclerosis. Annals of the New York
Academy of Sciences 947: 224-228.
Ouimet M, Barrett TJ, Fisher EA
(2019). HDL and Reverse Cholesterol Transport. Circulation
research 124 (10): 1505-1518.
Sarwar N, Danesh J, Eiriksdottir G,
Sigurdsson G, Wareham N, Bingham S, et al. (2007). Triglycerides
and the risk of coronary heart disease: 10,158 incident cases among
262,525 participants in 29 Western prospective studies.Circulation 115 (4): 450-458.
Seneviratne AN, Edsfeldt A, Cole JE,
Kassiteridi C, Swart M, Park I, et al. (2017). Interferon
Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic
Lesions by Impairing Efferocytosis. Circulation136 (12): 1140-1154.
Shen L, Gong F, Tian W, Li W, Zhang
F, Qian J, et al. (2013). Anti-inflammatory effects of arsenic
trioxide eluting stents in a porcine coronary model. BioMed
research international 2013: 937936.
Subbarayan PR, Ardalan B (2014). In
the war against solid tumors arsenic trioxide needs partners.Journal of gastrointestinal cancer 45 (3):363-371.
Tak PP, Firestein GS (2001).
NF-kappaB: a key role in inflammatory diseases. The Journal of
clinical investigation 107 (1): 7-11.
Tam LS, Kitas GD, González-Gay MA
(2014). Can suppression of inflammation by anti-TNF prevent progression
of subclinical atherosclerosis in inflammatory arthritis?Rheumatology (Oxford, England) 53 (6):1108-1119.
Tang T, Gong T, Jiang W, Zhou R
(2018). GPCRs in NLRP3 Inflammasome Activation, Regulation, and
Therapeutics. Trends in pharmacological sciences39 (9): 798-811.
Tie C, Gao K, Zhang N, Zhang S, Shen
J, Xie X, et al. (2015). Ezetimibe Attenuates Atherosclerosis
Associated with Lipid Reduction and Inflammation Inhibition. PloS
one 10 (11): e0142430.
Usui F, Shirasuna K, Kimura H,
Tatsumi K, Kawashima A, Karasawa T, et al. (2012). Critical role
of caspase-1 in vascular inflammation and development of atherosclerosis
in Western diet-fed apolipoprotein E-deficient mice. Biochemical
and biophysical research communications 425 (2):162-168.
Wassmann S, Stumpf M, Strehlow K,
Schmid A, Schieffer B, Böhm M, et al. (2004). Interleukin-6
induces oxidative stress and endothelial dysfunction by overexpression
of the angiotensin II type 1 receptor. Circulation research94 (4): 534-541.
Zhang K, Zhao P, Guo G, Guo Y, Tian
L, Sun X, et al. (2016). Arsenic Trioxide Attenuates NF-κB and
Cytokine mRNA Levels in the Livers of Cocks. Biological trace
element research 170 (2): 432-437.
Zhang R, Han S (2018). Cereal Fiber
Ameliorates High-Fat/Cholesterol-Diet-Induced Atherosclerosis by
Modulating the NLRP3 Inflammasome Pathway in ApoE(-/-) Mice.66 (19): 4827-4834.
Zhang S, Zhang Y, Li S, Li Z (2017).
Efficacy of arsenic trioxide drug-eluting stents in the treatment of
coronary heart disease. Experimental and therapeutic medicine13 (4): 1634-1636.
Zhao D, Tong L, Zhang L, Li H, Wan Y,
Zhang T (2016). Tanshinone II A stabilizes vulnerable plaques by
suppressing RAGE signaling and NF-κB activation in
apolipoprotein-E-deficient mice. Molecular medicine reports14 (6): 4983-4990.
Zhao Y, Du R, Zhou T, Yang D, Huang
Y, Wang Y, et al. (2018). Arsenic Trioxide-Coated Stent Is an
Endothelium-Friendly Drug Eluting Stent. 7 (15):e1800207.
Zhao Y, Zang G, Yin T, Ma X, Zhou L,
Wu L, et al. (2021). A novel mechanism of inhibiting in-stent
restenosis with arsenic trioxide drug-eluting stent: Enhancing
contractile phenotype of vascular smooth muscle cells via YAP pathway.Bioactive materials 6 (2): 375-385.